NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease

被引:28
|
作者
Khot, Mayuri [1 ]
Sood, Anika [1 ]
Tryphena, Kamatham Pushpa [1 ]
Khan, Sabiya [1 ]
Srivastava, Saurabh [2 ]
Singh, Shashi Bala [1 ]
Khatri, Dharmendra Kumar [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER Hyderabad, Dept Pharmacol & Toxicol, Mol & Cellular Neurosci Lab, Hyderabad 500037, Telangana, India
[2] Natl Inst Pharmaceut Educ & Res NIPER Hyderabad, Dept Pharmaceut, Hyderabad 500037, Telangana, India
关键词
NLRP3; Parkinson?s disease; Mitochondria; Neuroinflammation; Cytokines; ALPHA-SYNUCLEIN; COMPLEX-I; NEURODEGENERATIVE DISEASES; ROTENONE MODELS; CELL-DEATH; DYSFUNCTION; ACTIVATION; INFLAMMATION; MECHANISMS; MICE;
D O I
10.1016/j.ejphar.2022.175300
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative condition for which no approved treatment exists to prevent collective neuronal death. There is ample evidence that mitochondrial dysfunction, reactive oxygen species (ROS), and associated caspase activity underlie the pathology observed. Neurons rely on mitochondrial activity since they have such high energy consumption. Therefore, it is not surprising that mitochondrial al-terations favour neuronal degeneration. In particular, mitochondrial dysregulation contributes to PD, based on the observation that mitochondrial toxins can cause parkinsonism in humans and animal models. Also, it is known that inflammatory cytokine-mediated neuroinflammation is the key pathogenic mechanism in neuronal loss. In recent years, the research has focussed on mitochondria being the platform for nucleotide-binding oligomerization domain-like receptors 3 (NLRP3) inflammasome activation. Mitochondrial dysfunction and NLRP3 activation are emerging as critical players in inducing and sustaining neuroinflammation. Moreover, mitochondrial-derived ROS and mitochondrial DNA (mtDNA) could serve as the priming signal for forming inflammasome complexes responsible for the activation, maturation, and release of pro-inflammatory cytokines, including interleukin-1(IL-1) and interleukin-18 (IL-18). The current review takes a more comprehensive approach to elucidating the link between mitochondrial dysfunction and aberrant NLRP3 activation in PD. In addition, we focus on some inhibitors of NLRP3 inflammatory pathways to alleviate the progression of PD.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
    Yun Zhang
    Zhifang Dong
    Weihong Song
    Signal Transduction and Targeted Therapy, 5
  • [32] NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease
    Tao, Shuqi
    Fan, Wenyuan
    Liu, Jinmeng
    Wang, Tong
    Zheng, Haoning
    Qi, Gaoxiu
    Chen, Yanchun
    Zhang, Haoyun
    Guo, Zhangyu
    Zhou, Fenghua
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (04) : 1383 - 1398
  • [33] Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's Disease
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (08): : 1203 - 1204
  • [34] NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease
    von Herrmann, Katharine M.
    Salas, Lucas A.
    Martinez, Eileen M.
    Young, Alison L.
    Howard, Joseph M.
    Feldman, Mary S.
    Christensen, Brock C.
    Wilkins, Owen M.
    Lee, Stephen L.
    Hickey, William F.
    Havrda, Matthew C.
    NPJ PARKINSONS DISEASE, 2018, 4
  • [35] NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
    Katharine M. von Herrmann
    Lucas A. Salas
    Eileen M. Martinez
    Alison L. Young
    Joseph M. Howard
    Mary S. Feldman
    Brock C. Christensen
    Owen M. Wilkins
    Stephen L. Lee
    William F. Hickey
    Matthew C. Havrda
    npj Parkinson's Disease, 4
  • [36] A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease
    Chatterjee, Abhijit
    Mohapatra, Jogeswar
    Sharma, Manoranjan
    Jha, Abhishek
    Patro, Randeep
    Das, Debajeet
    Patel, Hiren
    Patel, Harilal
    Chaudhari, Jaimin
    Borda, Nilesh
    Viswanathan, Kasinath
    Sharma, Bhavesh
    Bhavsar, Harsh
    Patel, Ashvin
    Ranvir, Ramchandra
    Sundar, Rajesh
    Agarwal, Sameer
    Jain, Mukul
    BRAIN RESEARCH, 2024, 1842
  • [37] Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Parkinson's disease
    Lu, Ranran
    Zhang, Lijie
    Yang, Xinling
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [38] NLRP3 Inflammasomes: Dual Function in Infectious Diseases
    Li, Yanbo
    Qiang, Rui
    Cao, Zhengmin
    Wu, Qingjuan
    Wang, Jiuchong
    Lyu, Wenliang
    JOURNAL OF IMMUNOLOGY, 2024, 213 (04):
  • [39] Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
    Ayyubova, Gunel
    Madhu, Leelavathi N.
    MOLECULAR NEUROBIOLOGY, 2025,
  • [40] Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease
    Haque, Md Ezazul
    Akther, Mahbuba
    Jakaria, Md
    Kim, In-Su
    Azam, Shofiul
    Choi, Dong-Kug
    MOVEMENT DISORDERS, 2020, 35 (01) : 20 - 33